Ascletis Pharma Inc. (OTCMKTS:ASCLF – Get Free Report) shares dropped 25.2% during trading on Thursday . The stock traded as low as $0.15 and last traded at $0.15. Approximately 3,000 shares were traded during mid-day trading, a decline of 29% from the average daily volume of 4,243 shares. The stock had previously closed at $0.20.
Ascletis Pharma Price Performance
The firm’s 50-day moving average price is $0.20 and its two-hundred day moving average price is $0.21.
Ascletis Pharma Company Profile
Ascletis Pharma Inc, a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China and internationally. The company offers Ritonavir oral tablet, a pharmacokinetic booster of various oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid; ASCLEVIR and GANOVO for the treatment of Hepatitis C virus.
See Also
- Five stocks we like better than Ascletis Pharma
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- MarketBeat Week in Review – 5/20 – 5/24
- Are Penny Stocks a Good Fit for Your Portfolio?
- NASDAQ 100 vs. NASDAQ Composite: A Detailed Breakdown of NASDAQ
- What Does Downgrade Mean in Investing?
- These 2 Retail Traders Favorites are Nearing Major Breakouts
Receive News & Ratings for Ascletis Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascletis Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
